News
NMPA accepts clinical trial application for monkeypox vaccine
Updated: Jul 20, 2023
chinadaily.com.cn
Print
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
